References
- Malvezzi M , BertuccioP, LeviFet al. European cancer mortality predictions for the year 2014. Ann. Oncol.25, 1650–1656 (2014).
- Yeo TP . Demographics, epidemiology and inheritance of pancreatic ductal adenocarcinoma. Semin. Oncol.42, 8–18 (2015).
- Vincent A , HermanJ, SchulickR, HrubanRH, GogginsM. Pancreatic cancer. Lancet378, 607–620 (2011).
- Callery M , ChangK, FishmanE, TalamontiMS, William TraversoL, LinehanDC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Annals. Surg. Oncol.16(7), 1727–1733 (2009).
- National Comprehensive Cancer Network (NCCN) . NCCN clinical practice guidelines in oncology. www.nccn.org/professionals/physician_gls/f_guidelines.asp
- Katz M , PistersPW, EvansDBet al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J. Am. Coll. Surg.206(5), 833–846 (2007)
- Conroy T , DesseigneF, YchouMet al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med.364, 1817–1825 (2011).
- Burris HA , MooreMJ, AndersenJet al. Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol.15, 2403–2413 (1997)
- Ducreux M , CuhnaAS, CaramellaCet al. ESMO guidelines committee. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol.26(Suppl. 5), v56–v68 (2015).
- Denost Q , LaurentC, AdamJPet al. Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head. HPB (Oxford)15, 716–723 (2013).
- Cunningham D , AllumWH, StenningSPet al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med.355(1), 11–20 (2006).
- Grossman HB , NataleRB, TangenCM. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med.349(9), 859–866 (2003).
- Thompson AM , Moulder-ThompsonSL. Neoadjuvant treatment of breast cancer. Ann. Oncol.23(Suppl. 10), x231–x236 (2012).
- Assifi MM , LuX, EiblG, ReberHA, LiG, HinesOJ. Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of Phase II trials. Surgery150, 466–473 (2011).
- Gillen S , SchusterT, Meyer Zum BuschenfeldeC, FriessH, KleeffJ. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med.7, e1000267 (2010).